MENU

AGYTF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Allergy Therapeutics (AGYTF) Ownership - Who owns Allergy Therapeutics?

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Dominion Way

Phone

+44 1903844700

Employees

622

Web

https://www.allergytherapeutics.com

Details

Group

Domestic Stock Funds

Category

Pharmaceuticals

Capitalization

25.84M

P/E Ratio

49.26

Total Cash

41.39M

Projected Growth

N/A

Total Debt

9.93M

Revenue

79M

Risk (Beta)

902.37

Dividend Yield

N/A

Total Cash/Share

0.06

Total Debt/Equity

N/A

Revenue/Share

0.12 USD as % of share price

Fundamentals

AGYTF

Capitalization

25.8M

P/E Ratio

49.26

Risk (Beta)

902.37

Dividend Yield

N/A

Total Cash

41.4M

Total Cash/Share

0.06

Total Debt

9.93M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.12%

Revenue

79M

ROE

N/A

Book Value

55M

P/B Ratio

2.48

Cash Flow

N/A

Earnings

-0.01

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

652K

Current Ratio

3.80

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

302K

Float

N/A

Float - Current

N/A

Gross Income Margin

70.75

Revenue To Assets

-5.64

Shares Held By Institutions

76.2K

Shares Outstanding - Current

679M

Total Liabilities

37M

Total Volume MTD

N/A

Value

-1

Gain YTD

420.000

View a ticker or compare two or three

VS

VS

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

N/A

Address

Dominion Way

Phone

+44 1903844700

Employees

622

Web

https://www.allergytherapeutics.com